News from REMEDY

Marianne Skaar presents the EULAR recommendations for how user stakeholders should be involved in research on rheumatic diseases. The recommendations were updated in 2023.

The very first biopsies in the START project were the starting point for the operational part of an ambitious research effort. If everything goes as planned, it will make major contributions to diagnostics and treatment for patients with inflammatory arthritis.

Diakonhjemmet Foundation now becomes a partner in Health2B and a player in the arena of health innovation. This marks an important milestone in the development of sustainable solutions for health services.

How can the healthcare system handle chronic diseases in the future? Hege Johanne Magnussen has researched this and interviewed patients and healthcare personnel about the course of hand osteoarthritis. What contributes to and what stands in the way of the transfer of responsibilities, roles and tasks between practitioners and levels in the healthcare service?

In 2024, Diakonhjemmet Hospital set a new record with 14 doctorates in one year. This marks an important milestone in the work for better treatment and healthcare services. It is the result of a long-term commitment to research and innovation for the benefit of patients. Seven of the doctorates come from the REMEDY center. 

More than 50,000 Norwegians are taking a common type of medicine to suppress their immune system. A new study shows that these patients are no longer at high risk of severe COVID-19.

Conducting clinical trials requires more than just researchers. Support staff handle regulations, applications, and documents. They also contribute to good communication in the studies.

The board of the South-Eastern Regional Health Authority (RHF) has approved the allocation of regional research funds for 2025. The sum is NOK 149 million for a total of 86 research projects. A significant portion of this goes to Diakonhjemmet Hospital and projects in the REMEDY portfolio. In the picture you can see three of them who are happy to receive funds for research, doctoral fellow Camilla Fongen, consultant Birgitte Nellemann and professor Sella Provan.

Research shows that patients who participate in their own treatment often have better outcomes. In his PhD project, Joachim Sagen has investigated why user participation is important in healthcare. The study looks at how patient participation can make treatment and rehabilitation more successful.